
US Eyes Euro-Japanese Next-Gen Fighter Program
This month, Defense News reported that Paolo Zampolli, a close associate of US President Donald Trump and US special envoy to Italy, proposed US participation in the Euro-Japanese Global Combat Air Program (GCAP).
As of February 2025, Zampolli, who Trump recently appointed, held meetings with Italian officials, including Deputy Prime Minister Matteo Salvini, to bolster US-Italy defense ties.
In discussions with Italian media and Defense News, Zampolli advocated for a unified transatlantic fighter jet program, claiming it would benefit the US and GCAP members-the UK, Italy and Japan-by reducing costs and improving collaboration.
Zampolli also emphasized its potential to strengthen economic and commercial relations. It was not immediately clear if Zampolli was speaking in his personal capacity or at Trump's direction.
Italian politicians, including Foreign Minister Antonio Tajani, were surprised at Zampolli's mission, underscoring the proposal's nascent stage-US defense contractor Lockheed Martin reserved comments, directing inquiries to relevant governments.
The GCAP's capabilities could explain how US defense interests align or contrast with this program. In a May 2024 article for the Royal United Services Institute (RUSI), Trevor Taylor and Isabella Antinozzi mention that the GCAP retains significant human-machine integration, similar to the US Next-Generation Air Dominance (NGAD) program.
However, the NGAD program faces an uncertain future, with escalating costs, shifting strategic priorities and the rise of drone warfare casting doubt on its viability.
The US Air Force has paused the NGAD program , reassessing whether the US can maintain air superiority through a combination of existing platforms like the F-35, F-15EX, and F-22 alongside Collaborative Combat Aircraft (CCA).
Cost concerns are paramount, with each NGAD fighter projected to cost USD 250 million per unit. Some officials push for a scaled-down, software-driven light fighter as a cost-effective alternative .

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Comments
No comment